Hem › Metastaserande cancer › District of Columbia › Washington
Kliniska studier för Metastaserande cancer i Washington, DC
43 studier för Metastaserande cancer söker deltagare vid platser i och runt Washington (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekryterarFas 2
- Walter Reed National Military Medical Center, Bethesda · 7 mi bort
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
RekryterarFas 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
A Study of ASP3082 in Adults With Advanced Solid Tumors
RekryterarFas 1
- Georgetown University Hospital, Washington D.C.
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RekryterarFas 2/3
- Georgetown University, Washington D.C.
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekryterarFas 1
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
RekryterarFas 2
- The George Washington Medical facility Associates, Washington D.C.
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekryterarFas 2/3
- Georgetown University Medical Center - Department of Pharmacy, Oncology Pharmacy, Washington D.C.
- Georgetown University Medical Center, Washington D.C.
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekryterarFas 3
- Maryland Oncology Hematology, P.A., Silver Spring · 7 mi bort
- Maryland Oncology Hematology, P.A., Bethesda · 7 mi bort
- Maryland Oncology Hematology, P.A., Largo · 11 mi bort
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
RekryterarFas 1/2
- Georgetown University Medical Center, Washington D.C.
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RekryterarFas 3
- MedStar Washington Hospital Center, Washington D.C.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekryterarFas 3
- MedStar Washington Hospital Center, Washington D.C.
- American Oncology Partners, PA, Bethesda · 7 mi bort
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
RekryterarFas 1/2
- MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026), Washington D.C.
Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers
RekryterarFas 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi bort
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- Clinical Study Site, Washington D.C.
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
RekryterarFas 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
RekryterarFas 2
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi bort
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekryterarFas 3
- Sibley Memorial Hospital, Washington D.C.
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RekryterarFas 1/2
- Avenzo Therapeutics Recruiting Site, Washington D.C.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekryterarFas 3
- The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A., Bethesda · 7 mi bort
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
RekryterarFas 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors
RekryterarFas 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi bort
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
RekryterarFas 2
- Research Site, Washington D.C.
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers
RekryterarFas 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi bort
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
RekryterarFas 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi bort
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
RekryterarFas 1/2
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi bort
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RekryterarFas 3
- Research Site, Washington D.C.
- Research Site, Silver Spring · 7 mi bort
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
RekryterarFas 1/2
- George Washington University, Washington D.C.
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
RekryterarFas 3
- MedStar Washington Hospital Center, Washington D.C.
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
RekryterarFas 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
RekryterarFas 1/2
- Georgetown University Medical Center, Washington D.C.
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
RekryterarFas 3
- American Oncology Partners, P.A., Bethesda · 7 mi bort
Studying TAK-243 in Patients With Advanced Cancer
RekryterarFas 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi bort
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
RekryterarFas 2/3
- The Center for Cancer and Blood Disorders, Bethesda · 7 mi bort
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
RekryterarObservationsstudieFriska volontärer välkomna
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
RekryterarFas 3
- The George Washington University, Washington D.C.
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
RekryterarFas 2/3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RekryterarFas 2/3
- Georgetown University Medical Center, Washington D.C.
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
RekryterarFas 1
- National Cancer Institute, Bethesda · 7 mi bort
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
RekryterarFas 1
- Georgetown University Medical Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
RekryterarFas 1
- American Oncology Partners of Maryland, Bethesda · 7 mi bort
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RekryterarFas 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi bort
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi bort
Metastaserande cancer-studier i andra städer
- Houston, TX104 studier
- New York City, NY93 studier
- Nashville, TN70 studier
- Boston, MA63 studier
- Los Angeles, CA57 studier
- St. Louis, MO54 studier
- Arlington, VA53 studier
- Philadelphia, PA46 studier
- Chicago, IL45 studier
- San Antonio, TX44 studier
- Dallas, TX42 studier
- Seattle, WA39 studier
Andra studier i Washington
- Cancer (alla typer)58 studier
- Icke-småcellig lungcancer55 studier
- Bröstcancer46 studier
- Lungcancer41 studier
- Prostatacancer38 studier
- Övervikt33 studier
- Kolorektal cancer29 studier
- Hjärt-kärlsjukdom28 studier
- Blåscancer26 studier
- Akut myeloid leukemi24 studier
- Äggstockscancer23 studier
- Lymfom23 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.